Who should take Praluent (alirocumab)?

The U.S. Food and Drug Administration has approved Praluent (alirocumab) to lower LDL cholesterol in the following groups:
  • people who have a genetic condition called heterozygous familial hypercholesterolemia, which causes very high levels of cholesterol in the blood and increases the risk of heart attacks
  • people who have existing heart disease--those who have had a heart attack or stroke, for example--and who have not been able to lower their cholesterol enough using statin medications
In addition to taking Praluent, people in these groups should follow a heart-healthy lifestyle and continue taking a statin medication at the highest dosage that they can tolerate.

Continue Learning about High Cholesterol

Why You Need to Follow Your Cholesterol Treatment Plan
Why You Need to Follow Your Cholesterol Treatment Plan
If a blood test shows you have high levels of cholesterol—a waxy substance found in your blood—your clinician may want to put you on treatment. The ch...
Read More
What are statins?
Dr. Leopold D. Galland, MDDr. Leopold D. Galland, MD
Statins are the most frequently prescribed drugs in the U.S. Millions of Americans take statins, whi...
More Answers
What are the main categories of high cholesterol?
Dr. Jeanne Morrison, PhDDr. Jeanne Morrison, PhD
There are four main categories of high cholesterol that rate your risk for developing heart disease ...
More Answers
How common is high cholesterol in women?
Multiple Sclerosis FoundationMultiple Sclerosis Foundation
According to the National Women's Health Resource Center, more than 50 million American women have b...
More Answers

Important: This content reflects information from various individuals and organizations and may offer alternative or opposing points of view. It should not be used for medical advice, diagnosis or treatment. As always, you should consult with your healthcare provider about your specific health needs.